Clinical Trial Update: Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of M518101 in patients with plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• M518101

Snippet

Sponsor: Maruho Co., Ltd. | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED